Hospitalization

The COVID-19 hospitalization rate for adolescents aged 12 to 17 years in the United States rose in recent months following declines in January and February, according to data reported today in MMWR.

Incidence rates of diabetic ketoacidosis in the U.S. decreased by an average of 6.1% in 2018 and 2019 after increasing from 2011 to 2017, according to a study published in the Journal of Diabetes and Its Complications.

Data from a small real-world study demonstrated that receiving two doses of the Pfizer-BioNTech or Moderna COVID-19 vaccine is 94% effective against COVID-19 hospitalization among adults aged 65 years or older, researchers reported in MMWR.

Long-acting injectable antipsychotics provided significant benefit in prevention of hospitalization or relapse for schizophrenia compared with oral antipsychotics, according to study results published in The Lancet Psychiatry.

COVID-19 is more severe, with more complications and higher mortality, than influenza among patients with autoimmune disease, according to data published in Rheumatology.

A series of studies that assessed COVID-19-related risks and outcomes among patients with asthma were presented at this year’s virtual American Academy of Allergy, Asthma and Immunology Annual Meeting.

It is becoming clear that in addition to the immediate clinical effects of SARS-CoV-2, the novel coronavirus can have long-term manifestations, experts said.

Patients hospitalized with COVID-19 had a mortality risk that was nearly 3.5 times higher than those hospitalized with influenza, according to a study published in the Canadian Medical Association Journal.

Pregnant women with COVID-19 are more likely to die from the novel coronavirus than nonpregnant individuals similar in age, according to research published in the American Journal of Obstetrics and Gynecology.

Colchicine reduced hospitalization and mortality in patients with COVID-19 by more than 20%, according to topline results of the COLCORONA randomized trial.